Your browser doesn't support javascript.
loading
Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan.
Tajiri, Hitoshi; Arai, Katsuhiro; Kagimoto, Seiichi; Kunisaki, Reiko; Hida, Nobuyuki; Sato, Noriko; Yamada, Hiroshi; Nagano, Mieko; Susuta, Yutaka; Ozaki, Kunihiko; Kondo, Kazuoki; Hibi, Toshifumi.
Afiliación
  • Tajiri H; Department of Pediatrics, Osaka General Medical Center, Osaka, Japan. tajiriji@gh.opho.jp.
  • Arai K; Division of Gastroenterology, National Center for Child Health and Development, Tokyo, Japan.
  • Kagimoto S; Division of General Pediatrics, Saitama Children's Medical Center, Saitama, Japan.
  • Kunisaki R; Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Hida N; Division of Internal Medicine, Department of Inflammatory Bowel Disease, Hyogo College of Medicine, Hyogo, Japan.
  • Sato N; Ikuyaku Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Yamada H; Ikuyaku Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Nagano M; Ikuyaku Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Susuta Y; Ikuyaku Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Ozaki K; Ikuyaku Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Kondo K; Ikuyaku Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Hibi T; Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
BMC Pediatr ; 19(1): 351, 2019 10 13.
Article en En | MEDLINE | ID: mdl-31607268

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Colitis Ulcerosa / Infliximab Tipo de estudio: Clinical_trials / Guideline Límite: Adolescent / Child / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: BMC Pediatr Asunto de la revista: PEDIATRIA Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Colitis Ulcerosa / Infliximab Tipo de estudio: Clinical_trials / Guideline Límite: Adolescent / Child / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: BMC Pediatr Asunto de la revista: PEDIATRIA Año: 2019 Tipo del documento: Article País de afiliación: Japón